ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
Project Oncology®ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
CRC Screening Strategies: Balancing Accuracy, Access, and Adherence
On the Frontlines of Colorectal CancerCRC Screening Strategies: Balancing Accuracy, Access, and Adherence
The Changing Landscape of CRC Screening and Prevention
On the Frontlines of Colorectal CancerThe Changing Landscape of CRC Screening and Prevention
Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Project Oncology®Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Project Oncology®Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
Project Oncology®Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
- advertisement
- 4 questions
- 3 questions
- 4 questions
- 2 questions
- 10 questions
- 4 questions
- advertisement
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Evaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Medical Industry FeatureEvaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
Early CAR T Cell Therapy Referral: The Missing Piece in Blood Cancer Treatment
Project Oncology®Early CAR T Cell Therapy Referral: The Missing Piece in Blood Cancer Treatment
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Project Oncology®Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Medical Industry FeatureLatest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
- 04/09/2026
- 04/09/2026
- 04/08/2026
- 04/08/2026
- 04/07/2026
- 04/07/2026